Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Shares owned by ‘insiders’.

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Jun 18, 2021 6:08pm

126 Views

Post# 33415482

RE:RE:Shares owned by ‘insiders’.

wofats wrote: 18.55% of the company is held by insiders?
That is quite high isn't it.

Exactly Wofats.

This has really been a 4-5 person business for the longest time so there wouldn't be many insiders holding shares. The initial CFO has been replaced.

Biggest holders are ...

Goodman with 22M shares, 2.4M options and 40K PSUs (held directly and indirectly).
CFO has 52K shares, 689K options and 53K PSUs.
Amal has 116K shares, 528K options, 14K PSUs and 7K RSUs.

Obviously, Goodman has a lot of shares and his personal rule continues to hold - even at Knight. He won't sell one share until he sells them all (as per Goodman).

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?